Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:   The reported securities represent 189,758,441 shares of Class A Common Stock that are issuable upon conversion of shares of Class B Common Stock on a one-for-one basis. The reported percentage is calculated assuming 412,659,271 shares of Common Stock outstanding based upon (i) 222,900,830 shares of Class A Common Stock outstanding as of July 25, 2025 as provided by the Issuer, as increased by (ii) 189,758,441 shares of Class A Common Stock that are issuable on a one-for-one basis upon conversion of shares of Class B Common Stock held by the Reporting Persons (as defined below).


SCHEDULE 13G




Comment for Type of Reporting Person:   The reported securities represent 189,758,441 shares of Class A Common Stock that are issuable upon conversion of shares of Class B Common Stock on a one-for-one basis. The reported percentage is calculated assuming 412,659,271 shares of Common Stock outstanding based upon (i) 222,900,830 shares of Class A Common Stock outstanding as of July 25, 2025 as provided by the Issuer, as increased by (ii) 189,758,441 shares of Class A Common Stock that are issuable on a one-for-one basis upon conversion of shares of Class B Common Stock held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person:   The reported securities represent 189,758,441 shares of Class A Common Stock that are issuable upon conversion of shares of Class B Common Stock on a one-for-one basis. The reported percentage is calculated assuming 412,659,271 shares of Common Stock outstanding based upon (i) 222,900,830 shares of Class A Common Stock outstanding as of July 25, 2025 as provided by the Issuer, as increased by (ii) 189,758,441 shares of Class A Common Stock that are issuable on a one-for-one basis upon conversion of shares of Class B Common Stock held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person:   The reported securities represent 189,758,441 shares of Class A Common Stock that are issuable upon conversion of shares of Class B Common Stock on a one-for-one basis. The reported percentage is calculated assuming 412,659,271 shares of Common Stock outstanding based upon (i) 222,900,830 shares of Class A Common Stock outstanding as of July 25, 2025 as provided by the Issuer, as increased by (ii) 189,758,441 shares of Class A Common Stock that are issuable on a one-for-one basis upon conversion of shares of Class B Common Stock held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person:   The reported securities represent 189,758,441 shares of Class A Common Stock that are issuable upon conversion of shares of Class B Common Stock on a one-for-one basis. The reported percentage is calculated assuming 412,659,271 shares of Common Stock outstanding based upon (i) 222,900,830 shares of Class A Common Stock outstanding as of July 25, 2025 as provided by the Issuer, as increased by (ii) 189,758,441 shares of Class A Common Stock that are issuable on a one-for-one basis upon conversion of shares of Class B Common Stock held by the Reporting Persons.


SCHEDULE 13G



 
BC Partners Holdings Limited
 
Signature:/s/ Mark Rodliffe, /s/ Karen Jamieson
Name/Title:Mark Rodliffe / Authorized Signatory, Karen Jamieson / Authorized Signatory
Date:08/05/2025
 
CIE Management IX Limited
 
Signature:/s/ Mark Rodliffe, /s/ Matthew Elston
Name/Title:Mark Rodliffe / Authorized Signatory, Matthew Elston / Authorized Signatory
Date:08/05/2025
 
Argos Holdings GP LLC
 
Signature:/s/ Michael Chang
Name/Title:Michael Chang / Authorized Signatory
Date:08/05/2025
 
Argos Holdings L.P.
 
Signature:/s/ Michael Chang
Name/Title:Michael Chang / Authorized Signatory
Date:08/05/2025
 
Citrus Intermediate Holdings L.P.
 
Signature:/s/ Michael Chang
Name/Title:Michael Chang / Authorized Signatory
Date:08/05/2025

Comments accompanying signature:  Exhibit I Joint Filing Agreement, dated as of February 12, 2024, incorporated by reference to this Schedule 13G.